Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2004
09/22/2004EP1458719A1 Pyridoquinoxaline antivirals
09/22/2004EP1458697A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators
09/22/2004EP1458686A1 Benzocyclodecane derivatives with antitumor activity
09/22/2004EP1458676A2 Compounds for the treatment of inflammatory disorders
09/22/2004EP1458382A1 Amide derivatives as gk activators
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004EP1283205B1 Naphthol derivatives
09/22/2004EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
09/22/2004EP1069118B1 Process for producing 4-thiazolylmethyl derivative
09/22/2004CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
09/22/2004CN1530106A Medicine composition for treating diabet mellitus
09/22/2004CN1530105A Medicine composition for treating diabets and mellitus
09/22/2004CN1167693C Herbicidal (4-Cl-2-2-O-benzothiazolyline-3-group) alkyl carboxylic ester compounds
09/22/2004CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands
09/22/2004CN1167691C Substituted eenzylthiazolidie-2,4-dione derivatives
09/22/2004CN1167416C Use of glucose uptake enhancer for reducing post-ischemic injury of heart
09/21/2004US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide
09/21/2004US6794403 Substituted benzoxazoles as estrogenic agents
09/21/2004US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
09/21/2004US6794401 Amino acid phenoxy ethers
09/21/2004US6794400 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/21/2004US6794392 Cell differentiation inducer
09/21/2004US6794378 Heterocyclic compounds and medical use thereof
09/21/2004US6794373 Contraceptive methods using benzimidazolones
09/21/2004CA2150131C Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity
09/21/2004CA2114017C Amide tetrazole acat inhibitors
09/16/2004WO2004078988A1 Process for production of aromatic diols
09/16/2004WO2004078754A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors
09/16/2004WO2004078345A1 Method for producing bisphenol catalysts and bisphenols
09/16/2004WO2004033652A3 Inhibitors of fatty acid amide hydrolase
09/16/2004WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
09/16/2004US20040181075 Process of making chalcone derivatives
09/16/2004US20040181067 Tri(cyclo) substituted amide compounds
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180942 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders
09/16/2004US20040180941 3-(1-[3-(1,3-Benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors
09/16/2004US20040180871 Anti-inflammatory compositions and methods
09/16/2004CA2517708A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors
09/15/2004EP1456202A1 Benzothiazoles
09/15/2004EP1456188A1 7-amino-benzothiazole derivatives as adenosine receptor ligands
09/15/2004EP1456187A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
09/15/2004EP1456186A1 Novel inhibitor compounds specific of secreted non-pancreatic human a sb 2 /sb phospholipase of group ii
09/15/2004EP1455792A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
09/15/2004EP1295878B1 Pyrazinone derivatives
09/15/2004EP1274695A4 New thiazol compounds and their preparations
09/15/2004EP1254135B1 Aminoheterocyclylamides as pesticides and antiparasitic agents
09/15/2004EP1169311A4 Oxazole and thiazole combinatorial libraries
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004EP0775689B9 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/15/2004CN1529698A Taiazole or oxazole derivatives which are useful in treatment of cardiovascular and related diseases
09/15/2004CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
09/14/2004US6790859 Therapy or reducing progression of hypertension or damage to a tissue caused by contact with elevated levels of reducing sugars in an animal, comprising administering to the animal an effective amount of thiazolium compounds
09/14/2004US6790850 Thiazolo(4,5-d)pyrimidine compounds
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004076386A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
09/10/2004WO2004075864A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/10/2004WO2004056727A8 Process of making chalcone derivatives
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004052837A3 Amino substituted hydroxyphenyl benzophenone derivatives
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004WO2004000215A3 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
09/10/2004CA2516842A1 Hydroxamic acid compounds comprising a bicylic heteroaryl group as hdac inhibitors
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176431 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use
09/09/2004US20040176430 Propargyl-trifluoromethoxy-amino-benzothiazole derivatives
09/09/2004US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors
09/09/2004US20040176427 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid
09/09/2004US20040176409 treating or preventing a metabolic disorder or an inflammatory condition; modulate the PPAR gamma receptor; diagnosis and treatment of: type II diabetes, hypercholesterolemia, and inflammatory disorders
09/09/2004US20040176364 Aryl substituted thiazinidinones and the use thereof
09/09/2004US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants
09/09/2004US20040176356 4-(Hydroxyalkyl-)-piperazinyl(thio)acetamide derivatives for treatment of cardiovascular disorders; antiarrhythmia agents; intermittent claudication, angina, congestive heart failure and myocardial infarction
09/09/2004US20040176334 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
09/09/2004DE10308580B3 Verfahren zur elektrophilen Substitution von Thiazolidinen oder Oxazolidinen Method for electrophilic substitution of thiazolidines or oxazolidines
09/08/2004EP1453817A1 Thiazole derivatives with fungicidal activity
09/08/2004EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453505A2 Use of pramipexole to treat amyotrophic lateral sclerosis
09/08/2004EP1289972B1 Serine protease inhibitors
09/08/2004CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes
09/08/2004CN1527822A Thiazole derivatives for treating PPAR related disorders
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1526706A Process of recovering 2-mercaptan benzothiazole from cefotaxime producing slag
09/08/2004CN1165522C Bradykinin receptor antagonists
09/07/2004US6787654 Forming high purity and yield material; cyclization, chlorination and crystallization of allyl isothiocyanate
09/07/2004US6787649 Simple production of cefotiam; acylating and deformylation
09/07/2004US6787622 Radical polymerizable compound having at least one connecting hetero atom
09/07/2004US6787569 Therapeutic guanidines
09/07/2004US6787552 PPAR delta activators
09/07/2004US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
09/02/2004WO2004074295A1 Thiazole cycle polymers, process for producing the same, synthesis intermediates thereof and utilization of the same
09/02/2004WO2004073709A1 Antimicrobial agents
09/02/2004WO2004073606A2 Sulfonamide derivatives as ppar modulators
09/02/2004WO2004066964A9 Amino acid phenoxy ethers
09/02/2004WO2004041256A3 Safe chemical uncouplers for the treatment of obesity
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors